Aprea Therapeutics Inc (APRE)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.91M
Last updated: Nov 17, 2026 at 4:17 PM ET
Aprea Therapeutics Inc (APRE) Stock Chart
Aprea Therapeutics (APRE) has a latest price of $0.45 on Nov 17, 2026, 64.8% below its 52-week high of $1.29. Its price fell 62.6% over the past 12 months. The month-end price fell 99.5% over the 5 years through Oct 2026, a compound annual decline of 65.5%.
Price Chart
From Oct 2019 to Oct 2026, its highest month-end close was $917.80 in Dec 2019 and its lowest $0.48 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart APRE with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for APRE.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 32.5%, and over 6 months it fell 43.4%. The month-end price fell 85.6% over the 3 years through Oct 2026, a compound annual decline of 47.6%.
| Period | Change |
|---|---|
| 1 month | -14.9% |
| 3 months | -32.5% |
| 6 months | -43.4% |
| 12 months | -62.6% |
| 12 months, with dividends | -62.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -85.6% | -47.6% |
| 5 years | -99.5% | -65.5% |
Price by Year
Its best calendar year was 2023, when the price fell 29.0%, and its weakest was 2020, when it fell 89.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.48 | -43.2% |
| 2025 | $0.85 | -74.1% |
| 2024 | $3.29 | -30.0% |
| 2023 | $4.70 | -29.0% |
| 2022 | $6.62 | -88.5% |
| 2021 | $57.40 | -41.7% |
| 2020 | $98.40 | -89.3% |
Trading Range
The price is 25.7% below its 50-day average of $0.61 and 38.2% below its 200-day average of $0.73.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.45 | |
| 52-week high | $1.29 | -64.8% |
| 52-week low | $0.40 | +13.3% |
| 50-day average | $0.61 | -25.7% |
| 200-day average | $0.73 | -38.2% |
Price Risk
Over 3 years, its largest fall from a peak was 95.2%.
| Measure | Value |
|---|---|
| 1-year beta | 0.68 |
| Largest fall, 1 year | -67.8% |
| Largest fall, 3 years | -95.2% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About APRE
What is APRE's 1-year price change?
Aprea Therapeutics's price fell 62.6% over the past 12 months. With dividends included, the 12-month total return was -62.6%.
What is APRE's 5-year price change?
Aprea Therapeutics's month-end price fell 99.5% over the 5 years through Oct 2026, a compound annual decline of 65.5%. These figures leave out dividends.
What is APRE's 52-week high and low?
Aprea Therapeutics's 52-week high is $1.29 and its 52-week low is $0.40. Its latest price of $0.45 on Nov 17, 2026 is 64.8% below the high.
What is APRE's beta?
Aprea Therapeutics's 1-year beta against the S&P 500 is 0.68, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 67.8%.
Is the APRE chart free?
Yes. Advanced Charting for APRE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
APRE pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors